Fig. 1S
Effect of 1 on the activation of PPAR-. NIH3T3 cells co-transfected with the vectors for pFA-GAL4-PPAR-, pFR-Luc, and pRL-CMV were exposed to compound for 16 h, and then the luciferase activities were determined. WY14643 (PPAR- agonist, 30 M) [1] and 0.01% DMSO (vehicle) were used as a positive control and a negative control, respectively. for pFA-GAL4-PPAR-, pFR-Luc, and pRL-CMV were exposed to compound for 16 h, and then the luciferase activities were determined. GW0742 (PPAR- agonist, 10 nM) [2] and 0.01% DMSO (vehicle) were used as a positive control and a negative control, respectively. pFA-GAL4-PPAR-, pFR-Luc, and pRL-CMV were exposed to compound for 16 h, and then the luciferase activities were determined. Rosiglitazone (PPAR- agonist, 10 M) [3] and 0.01% DMSO (vehicle) were used as a positive control and a negative control, respectively.
